Patheon has created Centers of Excellence for biopharmaceutical development at both its Swindon and Ferentino sites. These centers are staffed by highly-experienced scientists dedicated to the efficient development of biopharmaceuticals such as proteins, peptides and monoclonal antibodies (MAb) for customers in sterile liquid and lyophilized formats.
Specialized testing methods and in-house bio-analytical equipment allows Patheon scientists to efficiently formulate and develop your complex biopharmaceutical products rapidly.
Patheon’s extensive bio-analytical capabilities include:
- Reducing/Non-reducing Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
- Isoelectric Focusing
- Western Blotting
- Ultra Violet (UV) Spectroscopy
- Mass Spectrometry
- High Performance Liquid Chromatography (HPLC) Methods: Size Exclusion, Ion Exchange, Reversed Phase
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Capillary Electrophoresis
Our Ferentino, Italy location is dedicated entirely to the development of lyophilized products. These experienced scientists have been involved in the development of a number of large molecule product formulations and offer expertise in the cycle optimization of lyophilized products.
Our Swindon, UK site offers specialized development services for biopharmaceutical sterile liquid products, in addition to small molecule development capabilities.
Patheon’s biopharmaceutical development capabilities are fully scalable to commercial volumes within the Patheon network. From early phase development, through to scale-up and commercialization, Patheon is well positioned to accelerate the development of your biopharmaceutical products.